Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-08-21
2007-08-21
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S227800, C514S237800, C514S318000, C514S326000, C546S186000, C546S193000, C546S208000, C546S236000, C544S060000, C544S129000, C540S597000
Reexamination Certificate
active
11142738
ABSTRACT:
The present invention relates to compounds of formula I:and pharmaceutically acceptable salts thereof, to the preparation of such compounds and pharmaceutical compositions containing them. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
REFERENCES:
patent: 2006/0084679 (2006-04-01), McArthur et al.
patent: WO 02/076925 (2002-10-01), None
patent: WO 2004/037788 (2004-05-01), None
patent: WO 2004/043458 (2004-05-01), None
Burks 1994 in Johnson L.R. ed., Physiology of the Gastrointestinal Tract, Raven Press, NY, pp. 211-242.
Leurs et al., Br J. Pharmacol. 1991, 102, pp. 179-185.
Raithel et al., Int. Arch. Allergy Immunol. 1995, 108, 127-133.
Panula et al., Proc. Natl. Acad. Sci. USA 1984, 81, 2572-2576.
Inagaki et al., J. Comp. Neurol 1988, 273, 283-300.
Arrang et al., Nature 1983, 302, 832-837.
Arrang et al., Neuroscience 1987, 23, 149-157.
Clapham & Kilpatrik, Br. J. Pharmacol. 1982, 107, 919-923.
Blandina et al. in The Histamine H3 Receptor (Leurs RL and Timmermann H eds, 1998, pp. 27-40, Elsevier, Amsterdam, The Netherlands.
Masaki et al; Endocrinol. 2003, 144, 2741-2748.
Hancock et al., European J. of Pharmacol. 2004, 487, 183-197.
Timmermann, J. Med. Chem. 1990, 33, 4-11.
Gatti McArthur Silvia
Hertel Cornelia
Nettekoven Matthias Heinrich
Plancher Jean-Marc
Raab Susanne
Grazier Nyeemah
Hoffmann-La Roche Inc.
Johnston George W.
Megerditchian Samuel H.
Saeed Kamal A.
LandOfFree
Naphthaline derivatives as H3 inverse agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthaline derivatives as H3 inverse agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthaline derivatives as H3 inverse agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3895190